Drug intelligence / Profile preview

mometasone

Development stage
Approved
Lead developer
Organon
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Intranasal, Topical
01

Overview

Mometasone is a synthetic corticosteroid with anti-inflammatory, antipruritic (anti-itch), and vasoconstrictive properties. It is used to treat various inflammatory conditions including skin disorders (topical), allergic rhinitis and nasal polyps (nasal spray), and asthma (inhaled). Mometasone acts by binding to the glucocorticoid receptor in target cells. This leads to changes in gene transcription that suppress the production of pro-inflammatory proteins and mediators such as prostaglandins and leukotrienes. The drug also reduces the activity of immune cells involved in inflammation like mast cells and eosinophils. Mometasone has a high topical-to-systemic activity ratio due to extensive hepatic metabolism and low systemic bioavailability when administered locally[3][5]. It was developed primarily for its potent local effects with minimal systemic side effects. Developed by Organon and manufactured by Merck.

Brand names
Asmanex TwisthalerAsmanex HFANasonexNasonex 24HR AllergyNasonex24HR AllergyNasonex-24HR AllergySinuvaPropelPropel MiniElocon
Other names
mometasone furoate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on mometasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mometasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call